ReShape Lifesciences SG&A Expenses 2015-2024 | RSLS
ReShape Lifesciences sg&a expenses from 2015 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| ReShape Lifesciences Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $10 |
| 2023 | $18 |
| 2022 | $31 |
| 2021 | $33 |
| 2020 | $15 |
| 2019 | $17 |
| 2018 | $30 |
| 2017 | $29 |
| 2016 | $10 |
| 2015 | $3 |
| 2014 | $5 |
| ReShape Lifesciences Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1 |
| 2024-09-30 | $3 |
| 2024-06-30 | $3 |
| 2024-03-31 | $3 |
| 2023-12-31 | $3 |
| 2023-09-30 | $4 |
| 2023-06-30 | $5 |
| 2023-03-31 | $6 |
| 2022-12-31 | $6 |
| 2022-09-30 | $6 |
| 2022-06-30 | $10 |
| 2022-03-31 | $9 |
| 2021-12-31 | $8 |
| 2021-09-30 | $16 |
| 2021-06-30 | $6 |
| 2021-03-31 | $4 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $3 |
| 2020-03-31 | $4 |
| 2019-12-31 | $4 |
| 2019-09-30 | $2 |
| 2019-06-30 | $4 |
| 2019-03-31 | $6 |
| 2018-12-31 | $7 |
| 2018-09-30 | $6 |
| 2018-06-30 | $7 |
| 2018-03-31 | $10 |
| 2017-12-31 | $9 |
| 2017-09-30 | $8 |
| 2017-06-30 | $6 |
| 2017-03-31 | $6 |
| 2016-12-31 | $5 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $1 |
| 2015-12-31 | |
| 2015-09-30 | $1 |
| 2015-06-30 | |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.005B | $0.008B |
| ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA. | |||